Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
144.77
+0.43 (0.30%)
May 20, 2024, 10:30 AM EDT - Market open
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 147.64, with a low estimate of 135 and a high estimate of 160. The average target predicts an increase of 1.98% from the current stock price of 144.77.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for DGX stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 10 | 10 | 7 | 7 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 10 | 9 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $138 → $144 | Hold | Maintains | $138 → $144 | -0.53% | Apr 25, 2024 |
| Citigroup | Citigroup | Hold Maintains $135 → $145 | Hold | Maintains | $135 → $145 | +0.16% | Apr 24, 2024 |
| UBS | UBS | Hold Maintains $139 → $146 | Hold | Maintains | $139 → $146 | +0.85% | Apr 24, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $145 → $150 | Hold | Maintains | $145 → $150 | +3.61% | Apr 24, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $150 → $155 | Strong Buy | Maintains | $150 → $155 | +7.07% | Apr 24, 2024 |
Financial Forecast
Revenue This Year
9.50B
from 9.25B
Increased by 2.63%
Revenue Next Year
9.83B
from 9.50B
Increased by 3.52%
EPS This Year
8.84
from 7.49
Increased by 17.98%
EPS Next Year
9.50
from 8.84
Increased by 7.49%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.9B | 10.4B | 10.8B | 11.0B | 11.4B |
| Avg | 9.5B | 9.8B | 10.2B | 10.3B | 10.5B |
| Low | 9.2B | 9.4B | 9.7B | 9.6B | 9.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.9% | 9.4% | 9.6% | 8.2% | 11.3% |
| Avg | 2.6% | 3.5% | 3.6% | 0.7% | 2.6% |
| Low | -0.8% | -0.9% | -1.5% | -5.5% | -4.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.24 | 10.06 | 11.21 | 11.53 | 12.57 |
| Avg | 8.84 | 9.50 | 10.26 | 11.04 | 11.98 |
| Low | 8.52 | 8.95 | 9.34 | 10.67 | 11.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 23.4% | 13.8% | 18.1% | 12.3% | 13.8% |
| Avg | 18.0% | 7.5% | 8.1% | 7.6% | 8.5% |
| Low | 13.8% | 1.3% | -1.7% | 4.0% | 4.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.